Skip to content

Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children

Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children: A Randomized Double-blind Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01564290
Enrollment
54
Registered
2012-03-27
Start date
2011-02-28
Completion date
2012-02-29
Last updated
2012-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Diarrhea, Acute Gastroenteritis

Keywords

acute diarrhea, probiotics, children

Brief summary

The purpose of this study is to determine the effect of probiotic yogurt in acute watery diarrhea in children. The investigators will compare the effect of two different probiotics products.

Detailed description

Background: Acute Gastroenteritis is one of the most and frequent disease in the childhood, considering the advances in treatment, Lactobacillus Rahmnosus has being well described as a probiotic who reduces the number of days of hospitalization and also de the severity. Objectives: To evaluate the effect of the probiotic yogurt in the treatment of children who are between 10 months and 3 years old with acute non-dysenteric diarrhea. Methods: A randomized clinical trial, controlled, double-blind. The investigators will have two groups of patients : One group will receive Lactobacillus Rahmnosus in a yogurt presentation and the other one will receive Sacharomyces boulardii in a lyophilized form ; the parameters of evaluation are going to be the number of diarrhea stools by day, number of vomiting episodes, hours with fever, nutritional and immunization state.

Interventions

DIETARY_SUPPLEMENTProbiotic yogurt

Lactobacilus Rhamnonsus 100000000 UFC per mL. Dosage 50 mL twice daily fo 5 days.

Lyophilized probiotic, containing 250 mg per sachet dosage to about 2 times a day for 5 days.

Sponsors

Centro Pediatrico Albina de Patino
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Months to 36 Months
Healthy volunteers
No

Inclusion criteria

* All acute diarrhea

Exclusion criteria

* Severe malnourishment * Severe dehydration * Systemic infections

Design outcomes

Primary

MeasureTime frameDescription
Duration of diarrheafive daysparticipants will be followed for the duration of hospital stay, an expected average of 5 days

Secondary

MeasureTime frameDescription
Duration of feverfive daysparticipants will be followed for the duration of hospital stay, an expected average of 5 days
duration of vomitingfive daysparticipants will be followed for the duration of hospital stay, an expected average of 5 days
duration of hospitalizationfive daysparticipants will be followed for the duration of hospital stay, an expected average of 5 days

Countries

Bolivia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026